CD8A and neoplasm: Flow cytometric analysis of harvested tumors revealed a significant reduction in BODIPY-C16 intensity within CD8+ tumor-infiltrating lymphocytes (TILs), without dramatically changing the percentage of BODIPY+CD8+ T cells (Figure 5A and Supplemental Figure 8A).